Who is sponsoring NCT03400839?

NCT03400839 is sponsored by Universidade Estadual de Londrina.

What drugs are being tested in NCT03400839?

Interventions in NCT03400839: Daily physical activity levels, 6-minute walk test, Cardiopulmonary exercise testing, Muscle Function, Lung Function, Body composition, HRQoL - SGRQ-I, Symptoms - UCSD/SOBQ, HRQoL - SF36, Anxiety and depression, Symptoms - mMRC, Sleep quality, Sleepiness, Inflammatory markers and oxidative stress, Functional performance tests.

What condition does NCT03400839 study?

NCT03400839 studies Interstitial Lung Disease.

Is NCT03400839 still recruiting?

NCT03400839 is currently status unknown. Last updated 2 August 2021.

Last reviewed 2021-08-02 · How we verify

NCT03400839: BELIEVE-ILD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases

Status unknown Last updated 2 August 2021

What this trial tests

trial testing Daily physical activity levels in Interstitial Lung Disease in 105 participants. Status unknown.

Timeline

15 September 2017

Primary endpoint
1 October 2023

1 October 2023

Quick facts

Lead sponsor	Universidade Estadual de Londrina
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	105
Start date	15 September 2017
Primary completion	1 October 2023
Estimated completion	1 October 2023
Sites	1 location across Brazil

Drugs / interventions tested

Daily physical activity levels
6-minute walk test
Cardiopulmonary exercise testing
Muscle Function
Lung Function
Body composition
HRQoL - SGRQ-I
Symptoms - UCSD/SOBQ
HRQoL - SF36
Anxiety and depression
Symptoms - mMRC
Sleep quality
Sleepiness
Inflammatory markers and oxidative stress
Functional performance tests

Conditions studied

Interstitial Lung Disease — all drugs for Interstitial Lung Disease →

Sponsor

Universidade Estadual de Londrina — full company profile →

Who can join

Adults 40 to 75, any sex, with Interstitial Lung Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective cohort study will investigate whether progression of the interstitial lung diseases is related to specific clinical endpoints and their changes over time. Longitudinal data of patients will be compared to an age-matched control group during a follow-up of at least two years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Characteristics of Individuals with Interstitial Lung Diseases and Indication of End-of-Life Care.
Krinski G, Bertin LD, Pimpão HA, Silva H, et al · · 2023 · cited 3× · PMID 38068366 · DOI 10.3390/jcm12237314

Verify or expand the search:

Other recruiting trials for Interstitial Lung Disease

Currently open trials in the same condition.

NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
NCT07254338 — Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific · recruiting
NCT07269262 — SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers · NA · recruiting
NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
NCT07323732 — A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas · Phase 2 · recruiting

Other Universidade Estadual de Londrina trials

Trials by the same sponsor.

NCT06809920 — Analysis of Knee Joint of Patients with Anterior Cruciate Ligament Injury Undergoing Physiotherapy After Two Different S · NA · not yet recruiting
NCT06648421 — Reference Values for the One Repetition Maximum Test of Knee Extensors for Brazilians. · recruiting
NCT06621368 — Effect of Two Years of Resistance Training on Health Status in Postmenopausal Women: Longitudinal Study Active Aging. · NA · recruiting
NCT05872971 — Dry Needling and Lateral Hip Pain (GTPS) · NA · unknown
NCT05662579 — Core Resistance and Lateral Hip Pain · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03400839 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Estadual de Londrina
Last refreshed: 2 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03400839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing